Stock market update: Nifty Pharma index  advances  1.25%

The Nifty Pharma index closed 1.25 per cent up at 18815.6.

NEW DELHI: The Nifty Pharma index closed on a positive note on Friday.

Shares of Laurus Labs Ltd.(up 3.63 per cent), Sun Pharmaceutical Industries Ltd.(up 2.8 per cent), Gland Pharma Ltd.(up 2.36 per cent), Cipla Ltd.(up 2.25 per cent) and Ipca Laboratories Ltd.(up 1.87 per cent) ended the day as top gainers in the pack.

On the other hand, Abbott India Ltd.(down 2.2 per cent), GlaxoSmithKline Pharmaceuticals Ltd.(down 1.18 per cent), Divi's Laboratories Ltd.(down 0.98 per cent), Aurobindo Pharma Ltd.(down 0.82 per cent) and Lupin Ltd.(down 0.22 per cent) finished as the top losers of the day.

The Nifty Pharma index closed 1.25 per cent up at 18815.6.

Benchmark NSE Nifty50 index ended up 84.8 points at 22096.75, while the BSE Sensex stood up 190.75 points at 72831.94.

Among the 50 stocks in the Nifty index, 37 ended in the green, while 13 closed in the red.

Shares of Vodafone Idea, YES Bank, Indian Railway Fin, NHPC and Tata Steel were among the most traded shares on the NSE.

Shares of eMudhra, Vadilal Ind, The Hi-Tech Gears, Shriram Pistons and Star Cement hit their fresh 52-week highs in today's trade, while Medico Remedies, SCI Land and Assets, Compuage Infocom, M K Proteins and Future Supply Chain hit their fresh 52-week lows.

Source: Stocks-Markets-Economic Times

Останні публікації
Manufacturing and services PMIs headline Monday's economic calendar
20.09.2024 - 22:00
US nuclear regulator has not gotten application for Three Mile Island restart
20.09.2024 - 22:00
Calamos VP John Koudounis sells shares worth over $380k
20.09.2024 - 22:00
Biden readies $375 million arms aid package for Ukraine
20.09.2024 - 22:00
Nike, AAR Corp set to report earnings Monday
20.09.2024 - 22:00
SEC rules Fox can skip vote on labeling TV opinion shows
20.09.2024 - 22:00
Challenge to US drug price negotiation program revived by appeals court
20.09.2024 - 22:00
US stocks mixed as investors weigh FedEx slump, Fed outlook
20.09.2024 - 21:00
Kayne Anderson BDC director Schnabel buys $7.6k in shares
20.09.2024 - 21:00
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
20.09.2024 - 21:00
Murdoch-backed REA sweetens offer for UK's Rightmove to nearly $7.9 billion, FT reports
20.09.2024 - 21:00
US Fed's relaxed bank capital plan faces pushback from regulator, sources say
20.09.2024 - 21:00
US House votes to repeal Biden administration tailpipe emissions rules
20.09.2024 - 21:00
CAMP4 Therapeutics Files for Proposed IPO
20.09.2024 - 21:00
Germany to hold onto Commerzbank stake as lender aims for independence
20.09.2024 - 21:00

© Analytic DC. All Rights Reserved.

new
Аналіз трейдера Аналіз трейдера за 20.09.24
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.